FDA clears trial for implant infection technology (opens in new tab)
Solenic Medical received FDA approval of its investigational device exemption application, allowing the company to launch a pivotal clinical trial of its Sola-2 alternating magnetic field system for patients with periprosthetic joint infections. The study will evaluate the safety and effectiveness of the technology in patients with infected knee replacements and is intended to support […] The post appeared first on .
Read the original article